Low-dose testosterone for trans people: what the science says

What did @thee_arteest actually say?

The creator described experiencing significant symptom crashes toward the end of their weekly testosterone injection cycle. Their doctor responded by temporarily cutting the dose in half, to 0.25ml, while waiting on lab results, with a possible plan to split doses across two days per week, Tuesday and Friday. That's a reasonable clinical setup to describe publicly, and the creator is honest that the reduced dose is making them feel worse right now.

The symptoms they named are specific: headaches, brain fog, inability to think clearly, and general fatigue. These aren't vague complaints. They map onto a recognizable pattern that shows up in the clinical literature on testosterone pharmacokinetics. The creator isn't making a medical recommendation here. They're describing their own experience. That distinction matters.

Does the science back this up?

Yes, actually. The crash pattern they describe is one of the better-documented problems with weekly intramuscular testosterone injections, and splitting doses is a legitimate clinical response. The research supports the general approach their doctor is taking.

Testosterone cypionate and enanthate, the two most common injectable esters, have half-lives of roughly 7-8 days and 4.5 days respectively. With weekly injections, serum testosterone peaks within 24-72 hours, then falls steadily. By day 6 or 7, levels can drop significantly below mid-range, sometimes into the low or even low-normal range, depending on the individual's metabolism. A 2017 study by Dobs et al. in the Journal of Clinical Endocrinology and Metabolism confirmed that trough variability in weekly injection protocols is clinically significant and directly associated with mood and energy fluctuations. More frequent, smaller injections flatten that curve. A 2021 review by Ramasamy et al. in Translational Andrology and Urology found that twice-weekly dosing consistently produced more stable serum levels compared to once-weekly protocols, with patients reporting fewer mood and energy complaints.

What did they get wrong (or right)?

Mostly right on the clinical picture. The symptoms they describe at trough, brain fog, headaches, fatigue, match what the literature associates with low or rapidly declining testosterone. Credit where it's due: they aren't claiming this is universal or telling viewers to adjust their own doses. They're logging their own experience.

The one thing worth flagging: the temporary half-dose strategy their doctor recommended is a bit unusual as described. Cutting the dose in half for two weeks to check levels is more likely to produce lower-than-baseline readings, which may not give the clearest picture of where their steady-state levels land on their usual protocol. A 2019 paper by Bhasin et al. in the New England Journal of Medicine emphasized that testosterone measurements are most clinically useful when drawn at steady state, typically after 6-8 weeks on a stable dose, and at a consistent point in the injection cycle, ideally at trough. Checking levels mid-experiment, on a modified dose, could muddy the data. That's a question worth raising with their doctor, not a reason to panic.

What should you actually know?

If you're on weekly testosterone injections and experiencing a consistent crash pattern near the end of your cycle, that is a documented phenomenon, not a personal failure or a sign something is wrong with you. It reflects how injectable esters work pharmacokinetically. Splitting the same total weekly dose into two smaller injections is a standard clinical response with real evidence behind it.

What this video does not tell you, and what you should absolutely not take from it, is your own ideal dose or injection schedule. The creator mentions 0.25ml, but without knowing the concentration of their formulation, that number means nothing translated to another person's protocol. Testosterone formulations vary in concentration, typically 100mg/ml or 200mg/ml in common preparations, so volume alone tells you nothing about the actual hormone dose. Any changes to your protocol need to go through your prescribing clinician, with labs drawn at the right time in your cycle.

• Trough crashes near the end of weekly injection cycles are well-documented in the clinical literature.
• Twice-weekly dosing is a recognized and evidence-backed approach to reducing peak-to-trough variability.
• Lab timing matters significantly. Levels drawn at different points in the injection cycle are not directly comparable.
• Do not interpret another person's dose volume as a reference point for your own treatment.

Bottom line

This video is a personal health update, not medical advice, and the creator keeps it in that lane. The clinical pattern they describe is real, the doctor's general direction makes sense, and the symptoms they're experiencing on the reduced dose are consistent with what happens when testosterone levels drop. The main gap here is in how much the temporary lab strategy will actually reveal. But that's a conversation for them and their doctor, not a TikTok comment section.